Literature DB >> 33220034

Ultrasonography techniques in the preoperative diagnosis of parotid gland tumors - an updated review of the literature.

Sebastian Stoia1, Grigore Băciuț2, Manuela Lenghel3, Radu Badea4, Mihaela Băciuț5, Simion Bran6, Dinu Cristian7.   

Abstract

Preoperative diagnosis of parotid tumors plays a crucial role in selecting and planning the surgical treatment. Ultrasound (US) with its modern techniques can contribute to the differential diagnosis of parotid tumors. This paper aims to achieve a comprehensive review of the ultrasound techniques used in the differential diagnosis of parotid tumors, based on the latest literature data. Considering that most parotid gland tumors are located in the superficial lobe, US is frequently the first imaging technique used for the diagnosis of parotid tumors. Sonoelastography can provide additional data on the elasticity of parotid tumors, but there is an overlap between malignant and benign parotid tumors parameters. Contrast-enhanced ultrasound adds value to conventional ultrasound and allows a more complete characterization of parotid tumors. Many authors have reported promising results using contrast-enhanced ultrasound in the differential diagnosis of parotid tumors. Multiparametric ultrasound with a careful and systematic approach usually allows an accurate differential diagnosis of parotid tumors.

Entities:  

Year:  2020        PMID: 33220034     DOI: 10.11152/mu-2652

Source DB:  PubMed          Journal:  Med Ultrason        ISSN: 1844-4172            Impact factor:   1.611


  2 in total

1.  Perfusion analysis of benign parotid gland tumors by contrast-enhanced ultrasonography (CEUS).

Authors:  Hans J Welkoborsky; Maria Albers; Julian Küstermeyer
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-03-01       Impact factor: 2.503

2.  Is the combined use of ultrasonography (USG) and fine needle aspiration biopsy (FNAB) safe in parotis masses? Retrospective comprehensive comparison of 123 cases.

Authors:  Erkan Yıldız; Selçuk Kuzu; Çağlar Günebakan; Murat Özdemir; Abdulkadir Bucak; Orhan Kemal Kahveci
Journal:  Ir J Med Sci       Date:  2022-09-12       Impact factor: 2.089

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.